RxDoctor Payments Data

Patricia Finegan, NP

Nurse Practitioner · Champaign, ILNPI 1164597837

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 25 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $245, 2.4 times the $102 reported in 2021.

$627in general payments, 2019–2025

Across 25 payments — averaging $25.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$137
  • Boston Scientific$102
  • Nalu Medical, Inc.$101
  • MML US, Inc.$81
  • Amgen$78
  • Vertos Medical, Inc.$44
  • plus $84 from 5 others

What the payments were for

  • Food & beverage$627100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$627 in reported general payments places this provider in the 75th percentile of 4,869 nurse practitioner providers in Illinois.

See all nurse practitioner providers in Illinois →

Medicare billing

Part B allowed, 2024
$92,032
Medicare patients
338
Services billed
1,618

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl25$24,872
Hysingla ErHydrocodone Bitartrate30$20,791
Pregabalin419$10,641
Duloxetine Hcl367$5,389
Celecoxib152$5,129
Gabapentin368$4,542
MovantikNaloxegol Oxalate11$4,517
Morphine Sulfate ErMorphine Sulfate62$4,337
Fentanyl23$2,013
Tizanidine Hcl150$1,615
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen43$596
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen27$577
Sulindac16$330
Methadone Hcl21$202
Prednisone44$63

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Champaign

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →